Current Studies

Atopic Dermatitis

A prospective observational study of patients receiving Dupixent for Atopic Dermatitis. 

ENROLLMENT CLOSED

https://clinicaltrials.gov/ct2...

A phase 3 randomized, placebo-controlled, double-blinded study to evaluate Upadacitinib in adolescents and adult subjects with moderate to severe Atopic Dermatitis. 

ENROLLMENT CLOSED 

https://clinicaltrials.gov/ct2...

A phase 3B multi center, randomized, double-blind, double-dummy, active controlled study comparing the safety Upadacitinib to Dupilumab in adult subjects with moderate to severe Atopic Dermatitis.

ENROLLMENT OPEN

https://clinicaltrials.gov/ct2…

Psoriasis

A multicenter, open-label, randomized study to assess the pharmacokinetics, safety, and efficacy of two doses of Bimekizumab in adolescent study participants with moderate to severe plaque psoriasis.

ENROLLMENT CLOSED

https://www.clinicaltrials.gov...

A Phase 3B, multicenter, interventional, open-label study of adult subjects with moderate to severe plaque psoriasis who have a suboptimal response to Secukinumab or Ixekizumab and are switched to Risankizumab.

ENROLLMENT CLOSED

https://clinicaltrials.gov/ct2...

For more information contact Meagan Stewart at 660-956-7078 or email [email protected] .

Contact Us

If you would like to call us directly our phone number is +1 (660) 627-7546 or you can use the form below.

!
!
!

Please do not submit any Protected Health Information (PHI).

WHERE IS YOUR PAIN?

Learn how we can help with your pain